Welcome to visit Acta Anatomica Sinica! Today is
Chinese




Effects and mechanisms of periostin overexpression on invasion and migration of the nasopharyngeal carcinoma 6-10B cell line
WANG Hui-jie SHI Jin-feng XIE Yuan-jie ZENG Gu-qing DU Ya-lan HUANG Xing-qiong LONG Zhi-feng YU Jiang-dong LI Mei-xiang*
Acta Anatomica Sinica ›› 2014, Vol. 45 ›› Issue (4) : 500-506.
Effects and mechanisms of periostin overexpression on invasion and migration of the nasopharyngeal carcinoma 6-10B cell line
Objective To explore the effects and mechanisms of periostin overexpression on migration and invasion of nasopharyngeal carcinoma(NPC) cell line. Methods The recombinant plasmids [pCMV-neo (+)-periostin] and control plasmids [pCMV-neo (+)] were transfected into 6-10B cells using lipofectamine 2000TM reagent. The expression of periostin was detected with PCR and Western blotting. Transwell chamber invasion assay was employed to assay the migration and invasion of 6-10B cells before and after transfection. A gelatin zymogram was used to detect the activity of MMP-2 and MMP-9 in cultivated supernatant of 6-10B cells before and after transfection. The expression of integrin-αvβ5 was detected by immunohistochemistry(IHC) in 6-10Bperiostin cells, 6-10Bvector cells and 6-10B cells as well as normal nasopharyngeal mucosa (NNM) and NPC and at the same time periostin also was detected by immumohistochemistry in NNM and NPC, and densitometry analysis using image-pro plus 6.0 software, and the correlation between periostin and integrin-αvβ5 on NPC was assayed with statistics. Results Over expression of periostin promoted cell migration and invasion. The expression levels of integrin-αvβ5 in primary NPC and 6-10Bperiostin cells were significantly higher than those in NNM and 6-10Bvector, 6-10B cells. The expression in NPC of integrin-αvβ5 showed positively correlated with the expression of periostin (r=0.682, P<0.01). Conclusion Periostin plays an important role in regulation of cell migration and invasion probably by combining with integrin-αvβ5 to improve the activities of MMPs.
Periostin / Nasopharyngeal cancer / Metastasis / transfection / Transwell / Immunohistochemistry / Human
[1]Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma[J]. Lancet, 1997(9084), 350:1087-1091.
[2]Li MX, Xiao ZQ, Liu YF, et al. Quantitative proteomic analysis of differential proteins in the stroma of nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissue[J]. J Cell Biochem, 2009, 106(4):570-579.
[3]Kudo Y, Iizuka S, Yoshida M, et al. Periostin directly and indirectly promotes tumor lymphangiogenesis of head and neck cancer[J]. PLoS One, 2012, 7(8):e44488.
[4]Zhang Y, Zhang G, Li J, et al. The expression analysis of periostin in human breast cancer[J]. J Surg Res, 2010, 160(1):102-106.
[5]Xu D, Xu H, Ren Y, et al. Cancer stem cell-related gene periostin: a novel prognostic marker for breast cancer[J]. PLoS One, 2012, 7(10):e46670.
[6]Marsh D, Suchak K, Moutasim KA, et al. Stromal features are predictive of disease mortality in oral cancer patients[J]. J Pathol, 2011, 223(4):470-481.
[7]Cheng AL, Huang WG, Chen ZC, et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis[J]. Clin Cancer Res, 2008, 14(2):435-445.
[8]Wei WI, Sham JS. Nasopharyngeal carcinoma[J]. Lancet, 2005, 365(9476):2041-2054.
[9]Luo S, Zhao L, Wang J, et al. Clinical outcome for early-stage nasopharyngeal carcinoma with predominantly WHO II histology treated by intensity-modulated radiation therapy with or without chemotherapy in non-endemic region of China[J]. Head Neck, 2014, 36(6): 841-847.
[10]Deraz EM, Kudo Y, Yoshida M, et al. MMP-10/stromelysin-2 promotes invasion of head and neck cancer[J]. PLoS One, 2011, 6(10):e25438.
[11]Kim CJ, Sakamoto K, Tambe Y, et al. Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells[J]. Int J Oncol, 2011, 38(6):1759-1766.
[12]Bao S, Ouyang G, Bai X, e tal. Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway[J]. Cancer Cell, 2004, 5(4):329-339.[13]Li W, Saji S, Sato F, et al. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects[J]. Int J Biol Markers, 2013, 28(2):e117-130.
[14]Ting WC, Chen LM, Pao JB, et al. Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients[J]. Int J Med Sci, 2013, 10(8):1022-1027.
[15]Schmalfeldt B, Prechtel D, Harting K, et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer[J]. Clin Cancer Res, 2001, 7(8):2396-2404.
[16]Singer CF, Kronsteiner N, Marton E, et al. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions[J]. Breast Cancer Res Treat, 2002, 72(1):69-77.
[17]Utispan K, Sonongbua J, Thuwajit P, et al. Periostin activates integrin alpha5beta1 through a PI3K/AKTdependent pathway in invasion of cholangiocarcinoma[J]. Int J Oncol, 2012, 41(3):1110-1118.
[18]Hwang CF, Su CY, Huang SC, et al. Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma[J]. Cancer Lett, 2003, 189(2):231-236.
[19]Slattery ML, John E, Torres-Mejia G, et al. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study[J]. PLoS One, 2013, 8(5):e63165.
the National Natural Science Foundation of China
/
| 〈 |
|
〉 |